Citigroup’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Sell |
|
|||||
|
2025
Q1 | $838K | Sell |
|
|||||
|
2024
Q4 | $5.95M | Buy |
|
|||||
|
2024
Q3 | $4.8M | Sell |
|
|||||
|
2024
Q2 | $4.03M | Sell |
|
|||||
|
2024
Q1 | $3.8M | Sell |
|
|||||
|
2023
Q4 | $12.7M | Buy |
|
|||||
|
2023
Q3 | $6.87M | Sell |
|
|||||
|
2023
Q2 | $8.76M | Buy |
|
|||||
|
2023
Q1 | $9.3M | Sell |
|
|||||
|
2022
Q4 | $3.67M | Sell |
|
|||||
|
2022
Q3 | $6.4M | Sell |
|
|||||
|
2022
Q2 | $8.66M | Buy |
|
|||||
|
2022
Q1 | $9.49M | Sell |
|
|||||
|
2021
Q4 | $17.6M | Buy |
|
|||||
|
2021
Q3 | $220K | Sell |
|
|||||
|
2021
Q2 | $186K | Buy |
|
|||||
|
2021
Q1 | $32K | Sell |
|
|||||
|
2020
Q4 | $53K | Sell |
|
|||||
|
2020
Q3 | $154K | Sell |
|
|||||
|
2020
Q2 | $328K | Buy |
|
|||||
|
2020
Q1 | $95K | Sell |
|
|||||
|
2019
Q4 | $257K | Buy |
|
|||||
|
2019
Q3 | $23K | Buy |
|
|||||
|
2019
Q2 | $14K | Buy |
|
|||||
|
2019
Q1 | $8K | Buy |
|
|||||
|
2018
Q4 | $0 | Buy |
|
|||||
|
2018
Q3 | $0 | Sell |
|
|||||
|
2018
Q2 | $17K | Sell |
|
|||||
|
2018
Q1 | $18K | Sell |
|
|||||
|
2017
Q4 | $23K | Buy |
|
|||||
|
2017
Q3 | $19K | Hold |
|
|||||
|
2017
Q2 | $18K | Sell |
|
|||||
|
2017
Q1 | $132K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $0 | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $0 | Sell |
|
|||||
|
2014
Q4 | $1K | Buy |
|